Gilead signs Voluntary Licensing Agreements with Cipla, Hetero Labs, Jubilant Lifesciences, Mylan for remdesivir Read more
FDA launches interactive, PDF-based template to promote greater efficiency and consistency in preparation and review of 510(k) medical device applications Read more